Impact of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass on Postnatal Neurogenesis
Overview
Pulmonary Medicine
Authors
Affiliations
Background: Neurodevelopmental impairment is an important challenge for survivors after neonatal surgery with cardiopulmonary bypass (CPB). The subventricular zone, where most neural stem/progenitors originate, plays a critical role in cortical maturation of the frontal lobe. Promoting neurogenesis in the subventricular zone is therefore a potential therapeutic target for preserving cortical growth. Mesenchymal stromal cells (MSCs) promote endogenous regeneration in the rodent brain. We investigated the impact of MSC delivery through CPB on neural stem/progenitor cells and neuroblasts (ie, young neurons) in the piglet subventricular zone.
Methods: Two-week-old piglets (n = 12) were randomly assigned to one of three groups: (1) control, (2) deep hypothermic circulatory arrest, and (3) circulatory arrest, followed by MSC administration. MSCs (10 × 10 per kg) were delivered through CPB during the rewarming period. Neural stem/progenitors, proliferating cells, and neuroblasts were identified with immunohistochemistry at 3 hours after CPB.
Results: CPB-induced insults caused an increased proliferation of neural stem/progenitors (P < .05). MSC delivery reduced the acute proliferation. MSC treatment increased the number of neuroblasts in the outer region of the subventricular zone (P < .05) where they form migrating chains toward the frontal lobe. Conversely, the thickness of the neuroblast-dense band along the lateral ventricle was reduced after treatment (P < .05). These findings suggest that MSC treatment changes neuroblast distribution within the subventricular zone.
Conclusions: MSC delivery through CPB has the potential to mitigate effects of CPB on neural stem/progenitor cells and to promote migration of neuroblasts. Further investigation is necessary to determine the long-term effect of MSC treatment during CPB on postnatal neurogenesis.
Hillerer K, Gimsa U Front Neurosci. 2024; 18:1493605.
PMID: 39664450 PMC: 11631930. DOI: 10.3389/fnins.2024.1493605.
Kobayashi K, Kobayashi K, Liu C, Ryan J, Zurakowski D, Ishibashi N Pediatr Cardiol. 2024; .
PMID: 38918239 PMC: 11668907. DOI: 10.1007/s00246-024-03550-5.
Lu Y, Han Y, Zhou L, Shi G, Bai L, Wang K FEBS Open Bio. 2022; 12(12):2154-2165.
PMID: 36153697 PMC: 9714364. DOI: 10.1002/2211-5463.13493.
Commentary: Using cardiopulmonary bypass to deliver cellular therapy to the brain.
Burkhart H, Nakamura Y, Buckley K JTCVS Open. 2022; 6:222-223.
PMID: 36003587 PMC: 9390136. DOI: 10.1016/j.xjon.2021.03.005.
Dose Effect of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass.
Kobayashi K, Maeda T, Ayodeji M, Tu S, Chen A, Rajtboriraks M Ann Thorac Surg. 2022; 116(6):1337-1345.
PMID: 35952858 PMC: 10009803. DOI: 10.1016/j.athoracsur.2022.07.035.